AMANDA SIMINERIO: Open Payments
NPI 1497184709 · WATERFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,864 in 154 payments from 21 companies in 2025. Trend: 2023 $1,654 · 2024 $2,961 · 2025 $3,864
Food & beverage: $3,864
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $633 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $506 |
| Ardelyx, Inc. | 15 | $384 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $334 |
| Janssen Biotech, Inc. | 10 | $269 |
| Madrigal Pharmaceuticals | 4 | $268 |
| Phathom Pharmaceuticals, Inc. | 6 | $212 |
| Aimmune Therapeutics, Inc. | 7 | $194 |
| Gilead Sciences, Inc. | 9 | $167 |
| QOL Medical, LLC | 5 | $155 |
Products named: ENTYVIO, IBSRELA, XIFAXAN, TREMFYA, REZDIFFRA, SKYRIZI, RINVOQ, VOQUEZNA.
Industry payments across CT — which companies pay providers there.
